Imiquimod (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the Imiquimod drug offered from Glenmark Pharmaceuticals Inc., USA. This Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
| NON-PROPRIETARY NAME: | Imiquimod |
| SUBSTANCE NAME: | IMIQUIMOD |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-03-06 |
| END MARKETING DATE: | 0000-00-00 |
Imiquimod HUMAN PRESCRIPTION DRUG Details:
| Item Description | Imiquimod from Glenmark Pharmaceuticals Inc., USA |
| LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/g) |
| START MARKETING DATE: | 2012-03-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68462-536_f310518e-0cee-491d-b5ff-c1eb63ea7c1a |
| PRODUCT NDC: | 68462-536 |
| APPLICATION NUMBER: | ANDA201994 |
Other IMIQUIMOD Pharmaceutical Manufacturers / Labelers:
